Dihydrotestosterone in prostatic hypertrophy
Open Access
- 1 September 1970
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 49 (9) , 1737-1745
- https://doi.org/10.1172/jci106391
Abstract
To explore the relation between androgens and prostatic hypertrophy in man, the concentrations of testosterone, dihydrotestosterone, and androstenedione and the rate of conversion of testosterone to dihydrotestosterone have been measured in normal and hypertrophic prostate tissue. First, a double isotope derivative technique was adapted for the measurement of tissue androgen content in 15 normal and 10 hypertrophic prostates. Although there was no significant difference in the content of androstenedione and testosterone between the two types of tissue, the content of dihydrotestosterone was significantly greater in the hypertrophic tissue (0.60 ±0.10 μg/100 g) than in the normal glands (0.13 ±0.05 μg/100 g). Second, a regional study was performed in three normal prostates and four glands with early hypertrophy, and it was demonstrated that the dihydrotestosterone content was two and three fold greater in the periurethral area where prostatic hypertrophy usually commences than in the outer regions of the gland. Finally, the rate of conversion of testosterone to dihydrotestosterone has been measured under standardized conditions in tissue slices from 4 normal and 20 hypertrophic prostates. There was no significant difference in the rate of dihydrotestosterone formation between the two types of gland (6.0 ±0.8 and 7.8 ±0.5 μμmoles/15 mg of tissue per hr). While the mechanism by which dihydrotestosterone accumulation occurs remains unexplained, it is possible that the local accumulation of dihydrotestosterone may be involved in the pathogenesis of prostatic hypertrophy in man.Keywords
This publication has 21 references indexed in Scilit:
- A Comparative Study of the Conversion of Testosterone to 17β-Hydroxy-5α-androstan-3-one (Dihydrotestosterone) by Prostate and EpididymisJournal of Clinical Endocrinology & Metabolism, 1969
- The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate.1968
- A Double Isotope Procedure for the Determination of Progestins in Rat Ovarian Vein BloodEndocrinology, 1968
- CONVERSION OF TESTOSTERONE TO 5 ALPHA-ANDROSTAN-17BETA-OL-3-ONE BY RAT PROSTATE IN VIVO AND IN VITRO1968
- In vitro metabolism of testosterone-4-14C and Δ4-androstene-3,17-dione-414C in human skinBiochemistry, 1968
- Determination of testosterone and androst-4-ene-3,17-dione concentration in human plasmaSteroids, 1966
- Testosterone metabolism in prostate; formation of androstan-17-beta-ol-3-one and androst-4-ene-3, 17-dione, and inhibitory effect of natural and synthetic estrogens.1965
- Treatment of Benign Prostatic Hypertrophy With Hydroxyprogesterone CaproatePublished by American Medical Association (AMA) ,1965
- Metabolism of Testosterone by the Human ProstateJAMA, 1963
- Post-natal growth changes in the human prostate1944